Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
The evidence strongly supports implementing early response checkpoints at 4 weeks and prompt medication intervention for non-responders, challenging the traditional approach of prolonged behavioral therapy before pharmacological support
A., OToole, P
MTT assay was conducted using a microplate reader (SpectraMax)
Effect of peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, on dedifferentiated thyroid cancers
US$ 20.23
US$ 25.32
US$ 24.72
